The Street’s Key Stock Analysts Research Reports
$ALDX, $AMSC, $CARA, $CERN, $CNCE, $CTMX, $DRNA, $FEDU, $GLPG, $INTC, $QCOM
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of the Street’s Key analysts outlook for main issues for Friday, as follows:
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) analysts started as Buy and assigned a 21 fair value estimate at Janney. The firm likes its platform targeting inflammation with multiple upcoming catalysts, noting that Aldeyra is developing novel therapies to treat immune-mediated diseases and that its lead platform is designed to sequester reactive aldehyde species.
American Superconductor Corp. (NASDAQ:AMSC) was started with a Buy rating and assigned an 11 price target at Craig-Hallum. Shares have traded in a 52-wk range of 3.06 – 8.03, and 8.17 is the consensus target price.
Aquestive Therapeutics Inc. (NASDAQ:AQST) was started with an Outperform rating and assigned a 33 target price at Wedbush Securities. The firm considers Aquestive to be an opportunity to invest in proprietary PharmFilm technology that is being leveraged to develop a pipeline of 10 drugs and candidates and as an oral alternative in patients having difficulty swallowing pills or only having invasive options like injections.
Cara Therapeutics Inc. (NASDAQ:CARA) analysts started as Buy and assigned a 30 target price at Jefferies.
Cerner Corp. (NASDAQ:CERN) was started with an Equal Weight rating at Barclays.
Concert Pharmaceuticals Inc. (NASDAQ:CNCE) was started as Neutral with a 17 fair value estimate at Janney.
CytomX Therapeutics Inc. (NASDAQ:CTMX) analysts started with a Buy rating and assigned a 32 price target at H.C. Wainwright. The 52-wk trading range is 16.26 – 35.00, and the consensus target price is at 39.33.
Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) was started with a Buy rating and assigned a 27 price target at Citigroup.
Four Seasons Education Inc. (NYSE:FEDU) was downgraded to Sell from Neutral with a 4 price target at Citigroup.
Galapagos N.V. (NASDAQ:GLPG) analysts started with an Overweight rating at JPMorgan
Intel Corp. (NASDAQ: INTC) analyst raised INTC to Market Perform from Underperform with a 46 price target at Northland Securities. The consensus target price is at 56.06, and the 52-wk trading range is 36.16 – 57.60.
Qualcomm Inc. (NASDAQ:QCOM) analyst started with an Overweight rating and assigned a 95 price target at Barclays. Qualcomm has a 52-wk trading range of 48.56 – 72.75 and a consensus target price of 70.35.
Have a terrific weekend
Latest posts by Paul Ebeling (see all)
- The Street’s Key Stock Analysts Research Reports - September 24, 2018
- Tesla (NASDAQ:TSLA) Need Lots More Cash, What is Going to Happen? - September 24, 2018
- Commentary: Paul Ebeling on Wall Street - September 24, 2018